🔎 Trials Near Me

Hjem › Type 2-diabetes › Texas › Dallas

Type 2-diabetes kliniske forsøg i Dallas, TX

19 studier for Type 2-diabetes søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

RekruttererFase 3
  • North Texas Endocrine Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RekruttererFase 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • og 1 flere
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

RekruttererFase 3
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Rekrutterer
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Alle aldre · Alle køn · Opdateret 29. sep. 2026 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

RekruttererFase 2
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

RekruttererFase 2
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

RekruttererFase 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

RekruttererFase 2
  • Velocity Clinical Research - Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, Dallas
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

RekruttererFase 3
  • Research Institute of Dallas, Dallas
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

RekruttererFase 1/2
  • UT Southwestern Medical Center, Dallas
Alder 18 til 100 · Alle køn · Opdateret 4. aug. 2026 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

RekruttererFase 2
  • Zenos Clinical Research, Dallas
Alder 18 til 70 · Alle køn · Opdateret 15. jun. 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

RekruttererFase 2
  • Velocity Clinical Research Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Rekrutterer
  • UT Southwestern Medical Center, Dallas
Alder 18 til 60 · Alle køn · Opdateret 10. feb. 2026 · NCT05168605

Type 2-diabetes forsøg i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.